Walleye Capital
EW icon

Walleye Capital’s Edwards Lifesciences EW Stock Holding History

Walleye Capital’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$156K Sell
1,950
-270,921
-99% -$22.3M ﹤0.01% 3471
2025
Q4 		$23.3M Buy
272,871
+72,460
+36% +$5.95M 0.07% 242
2025
Q3 		$15.6M Buy
200,411
+191,974
+2,275% +$15M 0.06% 347
2025
Q2 		$660K Buy
8,437
+7,780
+1,184% +$580K ﹤0.01% 2402
2025
Q1 		$47.6K Sell
657
-4,135
-86% -$296K ﹤0.01% 3863
2024
Q4 		$355K Sell
4,792
-95,386
-95% -$6.68M ﹤0.01% 3280
2024
Q3 		$6.61M Buy
100,178
+79,049
+374% +$5.74M 0.01% 969
2024
Q2 		$1.95M Sell
21,129
-66,563
-76% -$5.89M ﹤0.01% 2133
2024
Q1 		$8.38M Buy
+87,692
New +$7.37M 0.01% 938
2022
Q3 		– Sell
-9,905
Closed -$953K – 3307
2022
Q2 		$942K Buy
+9,905
New +$1.03M 0.03% 680
2021
Q4 		– Sell
-6,166
Closed -$698 – 2164
2021
Q3 		$698 Buy
+6,166
New +$704K 0.02% 629
2019
Q3 		– Sell
-780
Closed -$48K – 1987
2019
Q2 		$48K Buy
780
+330
+73% +$20K 0.01% 1392
2019
Q1 		$29K Buy
+450
New +$25.7K ﹤0.01% 1301

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Walleye Capital's EW Position: Q1 2026 in Review

Walleye Capital reduced its Edwards Lifesciences (EW) stake by 99% in Q1 2026, selling an estimated $22.3M and leaving 1,950 shares worth $156K. The position accounts for ﹤0.01% of the portfolio, ranked #3471.

Walleye Capital first reported a position in EW in Q1 2019 and has held it in 13 quarters since. The position peaked at $23.3M in Q4 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Walleye Capital held 1,950 shares of Edwards Lifesciences worth $156K as of Q1 2026.
  • Walleye Capital sold 270,921 Edwards Lifesciences shares in Q1 2026, an estimated $22.3M.
  • Edwards Lifesciences made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #3471 holding.
  • Walleye Capital first reported a position in Edwards Lifesciences in Q1 2019 and has held it in 13 quarters since.
  • Walleye Capital's Edwards Lifesciences position peaked at $23.3M in Q4 2025.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.